- About us
- Join Putnam
Our client needed successful HTA evidence packages and submissions to achieve reimbursement across Europe for an innovative oncology treatment.
We developed and implemented an HTA evidence generation strategy, including economic models, systematic literature reviews, statistical analyses, and expert engagement. We identified, obtained, and analyzed additional RWE data on patient quality of life to further support the evidence package.
Our HTA team developed submissions for NICE and SMC, and provided support throughout the HTA processes, including representation at the HTA committees. Our HEOR experts also provided support on HTA processes, evidence requirements and economic modelling to local affiliates, partnering with our client to successfully achieve access for patients to the new treatment across Europe.